NEUCA S.A.'s latest marketcap:
As of 07/05/2025, NEUCA S.A.'s market capitalization has reached $857.44 M. According to our data, NEUCA S.A. is the 10528th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 857.44 M |
| Revenue (ttm) | 3.55 B |
| Net Income (ttm) | 40.55 M |
| Shares Out | 4.48 M |
| EPS (ttm) | 8.92 |
| Forward PE | 17.96 |
| Ex-Dividend Date | 07/15/2025 |
| Earnings Date | 08/29/2025 |
NEUCA S.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | zł857.44 M | -21.07% | 10528 |
| 12/30/2024 | zł3.9 B | -4.37% | 9130 |
| 12/29/2023 | zł4.08 B | 44.23% | 8476 |
| 12/30/2022 | zł2.83 B | -23.49% | 10682 |
| 12/30/2021 | zł3.7 B | 29.38% | 9840 |
| 12/30/2020 | zł2.86 B | 79.6% | 9315 |
| 12/30/2019 | zł1.59 B | 49.6% | 10959 |
| 12/28/2018 | zł1.06 B | -13.42% | 12113 |
| 12/29/2017 | zł1.23 B | -28.61% | 12134 |
| 12/30/2016 | zł1.72 B | 7.41% | 10114 |
Company Profile
About NEUCA S.A.
NEUCA S.A. is a leading wholesale distributor of pharmaceuticals in Poland, operating across multiple segments to serve healthcare professionals and patients.
Business Segments
- Wholesale Distribution of Medicines
- Manufacture of Pharmaceuticals
- Medical Operator
- Clinical Trials
- Insurance Activities
Products & Services
The company offers a diverse portfolio under brands like Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic, including:
- Rx & OTC medicines
- Dietary supplements & medical devices
- Dermocosmetics & hygiene products
- Personal protective equipment
- Diagnostic & dressing materials
Healthcare & Financial Services
- Medical care (prevention, diagnostics, treatment)
- Insurance, subscriptions, and occupational medicine
- TPA services & remote consultations
- Medical helpline & e-commerce platform (apteline.pl)
Additional Activities
- Clinical trial outsourcing & research centers
- Advertising & marketing for pharmaceutical entities
- Logistics services for manufacturers
Company Background
Founded in 1990 as Torfarm SA, the company rebranded as NEUCA S.A. in 2010. Headquartered in Torun, Poland, it remains a key player in the pharmaceutical and healthcare sectors.
Frequently Asked Questions
-
What is NEUCA S.A.'s (WSE-NEU) current market cap?As of 07/05/2025, NEUCA S.A. (including the parent company, if applicable) has an estimated market capitalization of $857.44 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does NEUCA S.A. (WSE-NEU) rank globally by market cap?NEUCA S.A. global market capitalization ranking is approximately 10528 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.